Taken together, our data suggest that probiotic HY7302 inhibits the synthesis of inflammatory cytokines by regulating MAPK signaling and MMP9 expression in HCE cells damaged by BAC treatment. Here, MMP9 is linked to minimally invasive lung adenocarcinoma.